Nav: Home

New study aims to validate pediatric version of sequential organ failure assessment

April 28, 2019

BALTIMORE - A new study aims to validate the pediatric version of Sequential Organ Failure Assessment score in the emergency department (ED) setting as a predictor of mortality in all patients and patients with suspected infection. Findings from the study will be presented during the Pediatric Academic Societies (PAS) 2019 Meeting, taking place on April 24 - May 1 in Baltimore.

In adult Sepsis-3, sepsis is defined as a Sequential Organ Failure Assessment (SOFA) score greater than or equal to 2 plus suspected infection. A pediatric version (pSOFA) was derived among pediatric intensive care unit (PICU) patients.

"Our study is the first evaluation of pSOFA and Sepsis-3 outside of the PICU setting in a broad, multi-centered cohort of children seeking emergency care," said Frances Balamuth, MD, PhD, MSCE, one of the authors of the study. "We found that hospital mortality is a very rare outcome in this setting due to the diverse population that seek care in the ED and differentiating it from prior areas of pSOFA study. We found that pSOFA in the ED has face validity in that we observed increasing mortality with increasing pSOFA scores in both the ED population overall, and in those with sepsis according to Sepsis-3 definitions. Interestingly, we found that an ED pSOFA score of greater than or equal to 2 had poor sensitivity for predicting in hospital death, and not surprisingly had better test characteristics in those with suspected infection compared to the ED population overall."

This study involved a retrospective observational study in seven U.S. children's hospitals using the Pediatric Emergency Care Applied Research Network (PECARN) Registry from January 1, 2012 through -March 31, 2018. It included all ED visits for patients less than 18 years.

There were 3,087,746 ED visits during the study period. The pSOFA scores ranged from 0 to 14, with median (IQR) of 0 (0, 0). There were 88,916 (2.9%) visits with pSOFA greater than or equal to 2. Visits with pSOFA greater than or equal to 2 had increased risk of death (RR 31.8 (95% CI 28.5, 35.7) and longer median length of stay (LOS) (116 [41, 358] versus 41 [20, 85] hours, p<0.001) compared to those with pSOFA <2. Increasing pSOFA scores were associated with increased hospital mortality. The pSOFA had fair discrimination for hospital mortality with AUROC 0.79 (95% CI 0.77, 0.81). There were 490,314 patients with suspected infection, of which 30,339 (6.2%) had sepsis, and 154 (0.03%) had septic shock. In these categories, hospital mortality was 0%, 0.8%, and 5.8% respectively; and median hospital LOS was 45, 83 and 164 hours, respectively. The pSOFA had increased discrimination for hospital mortality among patients with suspected infection (AUROC 0.86 [95% CI 0.84, 0.88]).

The study evaluated the pSOFA score in a large, multicenter sample of pediatric ED visits. The pSOFA greater than or equal to 2 was uncommon but associated with increased mortality. The pSOFA had fair discrimination for in-hospital mortality among all ED visits; and improved discrimination among patients with suspected infection.

Dr. Balamuth continued, "Because the pSOFA score incorporates laboratory values as components of the score, and many children in the ED setting appropriately do not undergo laboratory testing, the pSOFA score likely has limited utility in improving initial clinician sensitivity for mortality risk in children with possible infections. Additional risk stratification tools are needed that are specifically designed for improving sensitivity for the 'needle in the haystack' problem of finding pediatric severe sepsis in the emergency setting."

Dr. Balamuth will present findings from "Validation of the Pediatric Sequential Organ Failure Assessment Score and Evaluation of Sepsis-3 Definitions in the Pediatric Emergency Department" on Sunday, April 28 at 3:30 p.m. EDT. Reporters interested in an interview with Dr. Balamuth should contact PAS2019@piercom.com. Please note that only the abstracts are being presented at the meeting. In some cases, the researchers may have additional data to share with media.

The PAS 2019 Meeting brings together thousands of pediatricians and other health care providers to improve the health and well-being of children worldwide. For more information about the PAS 2019 Meeting, please visit http://www.pas-meeting.org.
-end-
About the Pediatric Academic Societies Meeting

The Pediatric Academic Societies (PAS) Meeting brings together thousands of pediatricians and other health care providers united by a common mission: to improve the health and well-being of children worldwide. This international gathering includes pediatric researchers, leaders in pediatric academics, clinical care providers and community practitioners. Presentations cover issues of interest to generalists as well as topics critical to a wide array of specialty and sub-specialty areas. The PAS Meeting will be the premier North American scholarly child health meeting. The PAS Meeting is produced through a partnership of four pediatric organizations that are leaders in the advancement of pediatric research and child advocacy: American Pediatric Society, Society for Pediatric Research, Academic Pediatric Association and American Academy of Pediatrics. For more information, please visit http://www.pas-meeting.org. Follow us on Twitter @PASMeeting and #PAS2019, and like us on Facebook.

Abstract: Validation of the Pediatric Sequential Organ Failure Assessment Score and Evaluation of Sepsis-3 Definitions in the Pediatric Emergency Department

Background: In adult Sepsis-3, sepsis is defined as a Sequential Organ Failure Assessment (SOFA) score greater than or equal to 2 plus suspected infection. A pediatric version (pSOFA) was derived among PICU patients.

Objective: Our aims were to validate the pSOFA score in the emergency department (ED) setting as a predictor of mortality in 1) all patients; and 2) patients with suspected infection.

Design/Methods: Retrospective observational study in 7 US children's hospitals using the Pediatric Emergency Care Applied Research Network (PECARN) Registry from 1/1/12-3/31/18. We included all ED visits for patients <18 years. using only ed data, psofa components (cardiovascular, respiratory, hematologic, hepatic, renal, neurologic) were assigned a score from 0 to 4. we compared hospital length of stay (los) and mortality for visits with greater than or equal 2 <2 calculated discrimination area under the roc curve (auroc). within subset suspected infection, defined by any infectious testing during visit, determined los sepsis (suspected infection + 2) septic shock vasoactive infusion serum lactate>2 mg/dL).

Results: There were 3,076,500 ED visits during the study period. pSOFA scores ranged 0 to 14, with median (IQR) of 0 (0, 0). There were 88,986 (2.9%) visits with pSOFA greater than or equal to 2. Visits with pSOFA greater than or equal to 2 had increased risk of death (RR 31.8 (95% CI 28.5, 35.7) and longer median LOS (54 [IQR] vs 39 [IQR] hours, p<0.001) compared to those with pSOFA <2. Increasing pSOFA scores were associated with increased hospital mortality. pSOFA had fair discrimination for hospital mortality with AUROC 0.77 (95% CI 0.75, 0.78); test characteristics in Table 1. There were 490,388 patients with suspected infection, of which 30,366 (6.2%) had sepsis, and 154 (0.03%) had septic shock. In these categories, hospital mortality was 0%, 0.9%, and 5.8% respectively; and median hospital LOS was 45, 83, and 164 hours, respectively. pSOFA had increased discrimination for hospital mortality among patients with suspected infection (AUROC 0.86 [95% CI 0.84, 0.88]).

Conclusion(s): We evaluated the pSOFA score in a large, multicenter sample of pediatric ED visits. pSOFA greater than or equal to 2 was uncommon but associated with increased mortality. pSOFA had fair discrimination for in-hospital mortality among all ED visits; and improved discrimination among patients with suspected infection.

Authors: Frances Balamuth, Halden Scott, Scott Weiss, Michael Webb, James Chamberlain, Lalit Bajaj, Holly Depinet, Larry Cook, Norma Jean Simon, Sara J. Davies Deakyne, Robert Grundmeier, Elizabeth Alpern

Authors/Institutions: F. Balamuth, Pediatrics, University of Pennsylvania Perelman School of Medicine andChildren's Hospital of Philadelphia, Philadelphia, Pennsylvania, UNITED STATES|H. Scott, L. Bajaj, Pediatrics, University of Colorado, Aurora, Colorado, UNITED STATES|S.L. Weiss, Department of Anesthesiology and Critical Care, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, UNITED STATES|N.E. Simon, E. Alpern, Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, UNITED STATES|M. Webb, L. Cook, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, UNITED STATES|J. Chamberlain, Children's National Medical Center, Washington, District of Columbia, UNITED STATES|H. Depinet, Cincinnati Children's Hospital, Cincinnati, Ohio, UNITED STATES|R.W. Grundmeier, Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, UNITED STATES|S.J. Deakyne Davies, Research Informatics & Analytics, Analytics Resource Center, Children's Hospital Colorado, Aurora, Colorado, UNITED STATES

Pediatric Academic Societies

Related Mortality Articles:

Highest mortality risks for poor and unemployed
Large dataset shows that income, work status and education have a clear influence on mortality in Germany.
Addressing causes of mortality in Zambia
Despite the fact that people in sub-Saharan Africa are now living longer than they did two decades ago, their average life expectancy remains below that of the rest of the world population.
Examining the link between caste and under-five mortality in India
In India, children that belong to disadvantaged castes face a much higher likelihood of not living past their fifth birthday than their counterparts in non-deprived castes.
Mortality rates rising for Gens X and Y too
Declining life expectancies in the US include Gen X and Y Americans, in addition to the older Baby Boomers.
Trust in others predicts mortality in the United States
Do you trust other people? It may prolong your life.
Breast cancer screening does not reduce mortality
Fewer and fewer women die from breast cancer in recent years but, surprisingly, the decline is just as large in the age groups that are not screened.
Cold fronts may increase stroke mortality
Study conducted in Southern Hemisphere's subtropical zone detects correlation between drop in temperature and rise in deaths from stroke, especially among women and older people.
Far 'over-the-hill' lies the plateau of human mortality
Above age 105, the rise in risk of death by age slows -- and even plateaus -- according to a new study, one that provides valuable insight into one of the most fundamental questions of human aging; Is there a fixed maximum lifespan for humans?
Associating frailty to cardiovascular disease and mortality
Frailty is common in elderly people with cardiovascular disease and goes along with elevated mortality.
Increasing tree mortality in a warming world
A mix of factors is contributing to an increasing mortality rate of trees in the moist tropics, where trees in some areas are dying at about twice the rate that they were 35 years ago.
More Mortality News and Mortality Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 3: Shared Immunity
More than a million people have caught Covid-19, and tens of thousands have died. But thousands more have survived and recovered. A week or so ago (aka, what feels like ten years in corona time) producer Molly Webster learned that many of those survivors possess a kind of superpower: antibodies trained to fight the virus. Not only that, they might be able to pass this power on to the people who are sick with corona, and still in the fight. Today we have the story of an experimental treatment that's popping up all over the country: convalescent plasma transfusion, a century-old procedure that some say may become one of our best weapons against this devastating, new disease.   If you have recovered from Covid-19 and want to donate plasma, national and local donation registries are gearing up to collect blood.  To sign up with the American Red Cross, a national organization that works in local communities, head here.  To find out more about the The National COVID-19 Convalescent Plasma Project, which we spoke about in our episode, including information on clinical trials or plasma donation projects in your community, go here.  And if you are in the greater New York City area, and want to donate convalescent plasma, head over to the New York Blood Center to sign up. Or, register with specific NYC hospitals here.   If you are sick with Covid-19, and are interested in participating in a clinical trial, or are looking for a plasma donor match, check in with your local hospital, university, or blood center for more; you can also find more information on trials at The National COVID-19 Convalescent Plasma Project. And lastly, Tatiana Prowell's tweet that tipped us off is here. This episode was reported by Molly Webster and produced by Pat Walters. Special thanks to Drs. Evan Bloch and Tim Byun, as well as the Albert Einstein College of Medicine.  Support Radiolab today at Radiolab.org/donate.